Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk
Liver steatosis and fibrosis were associated with the increased predicted ASCVD risk, with mediation effects from hs-CRP, HOMA-IR, RC, and non-HDL-C.
Authors
- Yuqi Jiang
- Zhi Chen (ORCID: https://orcid.org/0000-0002-9467-9151)
- Xü Lin (ORCID: https://orcid.org/0000-0002-6382-7414)
- Genfeng Yu
- Xingying Chen (ORCID: https://orcid.org/0009-0004-4991-5153)
- Dao-Yan Pan (ORCID: https://orcid.org/0000-0002-0381-0119)
- Hualin Duan
- Heng Wan (ORCID: https://orcid.org/0000-0003-3674-5920)
- Dongmei Wang (ORCID: https://orcid.org/0000-0002-7920-8626)
- Jie Shen (ORCID: https://orcid.org/0000-0001-6952-9541)
- Lan Liu (ORCID: https://orcid.org/0000-0002-2860-0943)
- Si‐Yang Maggie Liu (ORCID: https://orcid.org/0000-0002-3837-0758)
- Zihao Gui
Institutions
- Third Affiliated Hospital of Southern Medical University (CN)
- The First People's Hospital of Shunde (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1080/07853890.2025.2486594
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.83
Funders
- National Natural Science Foundation of China
- Guangdong Medical Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province